ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 132 filers reported holding ANTARES PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,299,000 | +17.3% | 2,999,779 | +2.2% | 0.00% | +100.0% |
| Q4 2021 | $10,481,000 | +1.1% | 2,935,962 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $10,370,000 | -15.0% | 2,848,983 | +1.8% | 0.00% | -50.0% |
| Q2 2021 | $12,205,000 | +11.9% | 2,799,516 | +5.5% | 0.00% | 0.0% |
| Q1 2021 | $10,911,000 | +11.9% | 2,654,791 | +8.6% | 0.00% | 0.0% |
| Q4 2020 | $9,749,000 | +48.6% | 2,443,539 | +0.5% | 0.00% | +100.0% |
| Q3 2020 | $6,561,000 | +2.0% | 2,430,310 | +3.9% | 0.00% | 0.0% |
| Q2 2020 | $6,430,000 | +18.7% | 2,338,263 | +1.9% | 0.00% | 0.0% |
| Q1 2020 | $5,415,000 | -72.9% | 2,294,526 | -46.0% | 0.00% | -50.0% |
| Q4 2019 | $19,958,000 | +191.1% | 4,246,402 | +107.1% | 0.00% | 0.0% |
| Q3 2019 | $6,857,000 | +7.0% | 2,050,200 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $6,410,000 | +21.9% | 1,948,338 | +12.3% | 0.00% | +100.0% |
| Q1 2019 | $5,258,000 | -39.9% | 1,735,406 | -46.1% | 0.00% | 0.0% |
| Q4 2018 | $8,756,000 | +80.8% | 3,219,444 | +123.3% | 0.00% | 0.0% |
| Q3 2018 | $4,844,000 | +36.1% | 1,442,027 | +4.5% | 0.00% | 0.0% |
| Q2 2018 | $3,560,000 | +24.6% | 1,379,873 | +6.2% | 0.00% | 0.0% |
| Q1 2018 | $2,857,000 | +11.9% | 1,298,980 | +1.2% | 0.00% | 0.0% |
| Q4 2017 | $2,554,000 | -39.8% | 1,283,758 | -2.0% | 0.00% | -50.0% |
| Q3 2017 | $4,243,000 | +10.7% | 1,309,831 | +10.1% | 0.00% | 0.0% |
| Q2 2017 | $3,832,000 | +40.8% | 1,190,138 | +24.2% | 0.00% | +100.0% |
| Q1 2017 | $2,721,000 | +27.7% | 958,234 | +4.8% | 0.00% | 0.0% |
| Q4 2016 | $2,130,000 | +55.1% | 914,605 | +11.9% | 0.00% | 0.0% |
| Q3 2016 | $1,373,000 | +70.1% | 817,343 | +6.2% | 0.00% | – |
| Q2 2016 | $807,000 | +0.6% | 769,440 | -16.6% | 0.00% | – |
| Q1 2016 | $802,000 | -27.6% | 922,527 | +0.7% | 0.00% | -100.0% |
| Q4 2015 | $1,108,000 | -28.0% | 916,528 | +1.2% | 0.00% | 0.0% |
| Q3 2015 | $1,539,000 | -12.6% | 905,847 | +7.0% | 0.00% | 0.0% |
| Q2 2015 | $1,760,000 | -11.5% | 846,340 | +15.3% | 0.00% | 0.0% |
| Q1 2015 | $1,988,000 | +17.8% | 733,721 | +11.7% | 0.00% | 0.0% |
| Q4 2014 | $1,688,000 | +42.2% | 656,812 | +1.2% | 0.00% | 0.0% |
| Q3 2014 | $1,187,000 | -30.7% | 648,765 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,714,000 | -22.9% | 642,220 | +1.1% | 0.00% | 0.0% |
| Q1 2014 | $2,223,000 | -20.4% | 635,235 | +1.9% | 0.00% | -50.0% |
| Q4 2013 | $2,793,000 | +35.4% | 623,439 | +22.7% | 0.00% | 0.0% |
| Q3 2013 | $2,063,000 | +2.6% | 508,199 | +5.2% | 0.00% | 0.0% |
| Q2 2013 | $2,011,000 | – | 483,298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |